Skip to main content
Home
TERUMO GLOBAL

Select Region

Show — Select Region Hide — Select Region
    • Regions/Countries
        • Japan
        • United States
            • Terumo Interventional Systems
            • Terumo Cardiovascular
            • MicroVention (Neurovascular)
            • Terumo Blood and Cell Technologies
            • Terumo Aortic
            • Terumo Medical Products
            • Terumo Medical Corp
            • Terumo Health Outcomes
        • Canada
        • Europe
        • Latin America
            • Mexico
            • Brazil
            • Colombia
            • Chile and Argentina
            • Latin America
        • Asia Pacific
        • Australia
        • Korea
        • Vietnam
        • China
        • India
    • Global Business website
        • Terumo Cardiovascular
        • Terumo Aortic
        • MicroVention (Neurovascular)
        • Terumo Blood and Cell Technologies
        • Pharmaceutical Solutions
  • About Terumo
    About Terumo
      • Dear Stakeholders
      • Terumo Group Identity
      • Terumo Group Code of Conduct
      • Corporate Profile
      • Corporate Governance
      • Compliance
      • Procurement Activity
      • Regulations and Standards
      • Directors and Executive Officers
      • History
      • TERUMO’s Purpose
      • Our Stories
      • Terumo's Response to COVID-19
  • Business Overview
    Business Overview
      • TIS Division (Terumo Interventional Systems)
      • Neurovascular Division (MicroVention)
      • Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division
      • Vascular Graft Division (Terumo Aortic)
      • Hospital Care Solutions Division / Life Care Solutions Division
      • Pharmaceutical Solutions Division
      • Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies)
  • Sustainability
    Sustainability
      • Sustainability News
      • Message from Top Management
      • Sustainability at the Terumo Group
      • Resolving Healthcare Challenges
      • Creating a Diverse and Inclusive Workplace
      • Reducing Environmental Footprint
      • Serving Our Communities
      • Report Library
      • GRI Standards Index
  • Technology
    Technology
      • Basic Information
          • Basic Information Top
          • Research and Development
          • Production and Supply
          • Intellectual Property
          • Terumo Fellows
      • Stories - Our Technologies
  • Investors
    Investors
      • Management Policy
          • Management Policy
          • Top Management Message
          • Business Risks
          • Disclaimer
          • IR Policy
      • Financial Highlights
      • IR Library
          • IR Library
          • Financial Statements
          • Presentations
          • Consolidated Financial Statements
          • Terumo Reports
      • IR Events
      • Shareholders & Stock
          • Shareholders Meeting
          • Stock Information
          • Shareholder Return
          • Credit Ratings and Corporate Bond
          • Analyst Coverage
          • Articles of Incorporation
          • Site Quote
      • IR Inquiries
  • News
    News
      • August 05, 2022
        Corporate
        Rika Plasma Donation System Reaches Critical Milestone with Plasma Collection from First Donor

        Terumo Blood and Cell Technologies’ new Rika system represents a new era in plasma collections

      • August 02, 2022
        Financial
        Notification Regarding Status of Acquisition of the Company's Own Shares (PDF 104.39 KB)

        (Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation)

      • August 02, 2022
        Corporate
        Terumo Announces Regulatory Approval of Drug-Device Combination Product Co-Developed with Kyowa Kirin

        Expected to Reduce the Burden on Patients Receiving Chemotherapy

      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
    • Global Network
      Global Network
        • Japan
        • North America
        • South America
        • Europe, Middle East and Africa
        • Greater China
        • Asia and Pacific

    Breadcrumb

    1. Home
    2. Investors
    Move to topTop

    Investors

    Japanese

    IR Information Top Image / Blue sky looking up from a skyscraper district
    Financial Results for
    the First Quarter of Fiscal Year Ending March 31, 2023
    August 9, 2022
    IR Library
    Audio Webcast

    Stock Quote

    Prime Market of TSE:

    Last Trade
    JPY
    Change
    JPY (%)
    Volume

    View Chart

    Image of the top message / Shinjiro Sato, President and CEO
    Top Management Message
    Shinjiro Sato, President and CEO
    5-Year Growth Strategy Key Visual/Image of a ship on the sea
    5-Year Growth Strategy
    2022 - 2026
    Terumo Report image / abstract image of the report and the earth
    Terumo Report
    Terumo Group Sustainability Image / Passing a white flower from parent to child's hand
    Sustainability

    What's New

    • August 12, 2022
      Q&A regarding Financial Results for the First Quarter of FYE 3/2023
    • August 10, 2022
      Audio webcast regarding Financial Results for FYE 3/2023
    • August 09, 2022
      Presentation regarding Financial Results for the First Quarter of FYE 3/2023
    • July 15, 2022
      Notice of Completion of Disposal of Treasury Shares as Restricted Stock Remuneration Plan (PDF 99.92 KB)
    • July 15, 2022
      Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants) (PDF 64.64 KB)
    View all
    Business Overview
    Introduction to the businesses operated by the Terumo Group
    /business
    Business introduction image / Two doctors performing catheterization
    Technology
    Introduction to Terumo's research and development activities and production system
    /technology
    Technology key visual / Guidewire production process

    Footer Menu

    Show — Footer Menu Hide — Footer Menu
      • About Terumo
          • About Terumo
          • Dear Stakeholders
          • Terumo Group Identity
          • Terumo Group Code of Conduct
          • Corporate Profile
          • Corporate Governance
          • Compliance
          • Procurement Activity
          • Regulations and Standards
          • Directors and Executive Officers
          • History
          • TERUMO’s Purpose
          • Our Stories
          • Terumo's Response to COVID-19
      • Business Overview
          • Business Overview
          • TIS Division (Terumo Interventional Systems)
          • Neurovascular Division (MicroVention)
          • Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division
          • Vascular Graft Division (Terumo Aortic)
          • Hospital Care Solutions Division / Life Care Solutions Division
          • Pharmaceutical Solutions Division
          • Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies)
      • Sustainability
          • Sustainability Overview
          • Sustainability News
          • Message from Top Management
          • Sustainability at the Terumo Group
          • Resolving Healthcare Challenges
          • Creating a Diverse and Inclusive Workplace
          • Reducing Environmental Footprint
          • Serving Our Communities
          • Report Library
          • GRI Standards Index
      • Technology
          • Technology Overview
          • Basic Information
              • Research and Development
              • Production and Supply
              • Intellectual Property
              • Terumo Fellows
          • Stories - Our Technologies
      • Investors
          • Investors
          • Management Policy
              • Top Management Message
              • Business Risks
              • Disclaimer
              • IR Policy
          • Financial Highlights
          • IR Library
              • Financial Statements
              • Presentations
              • Consolidated Financial Statements
              • Terumo Reports
          • IR Events
          • Shareholders & Stock
              • Shareholders Meeting
              • Stock Information
              • Shareholder Return
              • Credit Ratings and Corporate Bond
              • Analyst Coverage
              • Articles of Incorporation
              • Site Quote
          • IR Inquiries
      • News
          • News
          • Press Inquiries
      • Global Network
          • Japan
          • North America
          • South America
          • Europe, Middle East and Africa
          • Greater China
          • Asia and Pacific
    • About Terumo
    • Business Overview
    • Sustainability
    • Technology
    • Investors
    • News
    • Global Network

    Footer

    Show — Footer Hide — Footer
    • Terms and Conditions of Use
    • Privacy Policy
    • Cookie Policy
    • Cookie Settings
    • Social Media Policy
    • Site Map

    Copyright © 2022 Terumo Corporation, All Rights Reserved.